Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00428922 |
|---|---|
| Brief Title: | Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients |
| First Submitted : | January 29, 2007 |
| First Submitted that Met QC Criteria : | January 29, 2007 |
| First Posted : | January 30, 2007 (Estimate) |
| Results First Submitted : | November 10, 2015 |
| Results First Submitted that Met QC Criteria : | January 14, 2016 |
| Results First Posted : | February 12, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 11, 2018 |
| Last Update Posted : | August 9, 2018 |